THE EFFECT OF GUİDED IMAGERY ON PREMENSTRUAL SYNDROME
EFFECT OF GUİDED IMAGERY ON PREMENSİVE SYNDROME İN UNİVERSİTY STUDENTS
1 other identifier
interventional
48
1 country
1
Brief Summary
EFFECT OF GUIDED IMAGERY ON PREMENSTRUAL SYNDROME IN UNIVERSITY STUDENTS Premenstrual Syndrome (PMS) is a condition characterized by physical, behavioral, and emotional symptoms that appear at the end of the luteal phase, 7-10 days before menstruation, and resolve with the onset of menstruation. Symptoms include irritability, loss of control, anxiety, depression, sleep disturbances, decreased concentration, unexplained crying, fatigue, weakness, changes in appetite, edema, headaches, joint and muscle pain, breast tenderness, altered sexual activity, and social withdrawal. In young women, PMS can negatively affect self-confidence, social relationships, quality of life, and academic performance. PMS treatment aims to relieve both physical and psychological symptoms and may include dietary supplements and complementary-alternative therapies. Approaches such as reflexology, pilates, acupressure, music, exercise, and guided imagery have shown promising results in reducing premenstrual symptoms. Mind-body-based approaches in complementary therapies are known to support psychological well-being. Guided imagery, a form of mind-body communication, involves the flow of thoughts and the way the mind encodes, stores, and expresses sensory information. It is based on the understanding that the mind and body are interconnected and that mental processes can influence physical responses. Guided imagery has been shown to reduce stress, improve mood, enhance sleep quality, strengthen the immune system, reduce fatigue, and minimize nausea and vomiting. Although effective, research on the use of guided imagery to reduce PMS symptoms in university students is limited. This study aims to investigate the effect of guided imagery on premenstrual syndrome in this population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 24, 2025
CompletedFirst Posted
Study publicly available on registry
October 2, 2025
CompletedStudy Start
First participant enrolled
May 15, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
August 20, 2026
Study Completion
Last participant's last visit for all outcomes
December 15, 2026
May 1, 2026
February 1, 2026
3 months
September 24, 2025
April 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
premenstrual syndrome
The Premenstrual Syndrome Scale, developed by Gençdoğan (2006), is a five-point Likert-type instrument consisting of 44 items designed to assess the severity of premenstrual symptoms, based on DSM-III and DSM-IV-R criteria. In scoring, responses are rated as follows: "None" = 1 point, "Very little" = 2 points, "Sometimes" = 3 points, "Often" = 4 points, and "Always" = 5 points.
two months
Study Arms (2)
intervention group
ACTIVE COMPARATORAt baseline, students in both the intervention and control groups will complete the Introductory Characteristics Data Collection Form, the Premenstrual Syndrome Scale, and the WHO Quality of Life Scale. Students in the intervention group with high PMS scores will be instructed to practice guided imagery for 15 minutes daily during two consecutive menstrual cycles-specifically, during the seven days prior to menstruation when symptoms begin and the first four days of menstruation. The control group will receive no intervention. Throughout the study, intervention group participants will complete the Menstrual Cycle Follow-up Form and the Guided Imagery Follow-up Form, while control group participants will complete only the Menstrual Cycle Follow-up Form. After two cycles, both groups will again complete the Premenstrual Syndrome Scale and the WHO Quality of Life Scale.
control group
NO INTERVENTIONAt baseline, students in both the intervention and control groups will complete the Introductory Characteristics Data Collection Form, the Premenstrual Syndrome Scale, and the WHO Quality of Life Scale. No intervention will be applied to the control group; however, they will be asked to complete the Menstrual Cycle Follow-up Form throughout the study. After two menstrual cycles, both groups will again complete the Premenstrual Syndrome Scale and the WHO Quality of Life Scale.
Interventions
Guided imagery is a form of mind-body communication, defined as a flow of thoughts involving what we smell, taste, see, hear, and touch, or as the way the mind encodes, stores, and retrieves information. Guided imagery is based on the understanding that the mind and body are interconnected and that the mind can influence bodily functions. Stress and anxiety directly affect the brain and the immune system.
Eligibility Criteria
You may qualify if:
- Regular menstrual cycles (21-35 days over the last three cycles)
- Age 18 years or older
- No medical treatment for PMS
- Ability to communicate effectively in Turkish
- No psychiatric diagnosis or gynecological disorder (e.g., abnormal uterine bleeding, myoma, ovarian cysts)
- A score \>89 on the Premenstrual Syndrome Scale (PMSS)
- No prior participation in guided imagery training
You may not qualify if:
- Failure to perform guided imagery at the correct time or in the prescribed manner
- Irregular menstruation during the last three months
- Use of contraceptives
- Use of analgesics during menstruation while participating in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Başkent University
Ankara, 06790, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 24, 2025
First Posted
October 2, 2025
Study Start (Estimated)
May 15, 2026
Primary Completion (Estimated)
August 20, 2026
Study Completion (Estimated)
December 15, 2026
Last Updated
May 1, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share